“Advances in Renal Cancer” Journalists’ Award 2011 announced

Leverkusen, July 2010 – Renal cell carcinoma is one of the most common cancers worldwide. However, there still is a lack of awareness of the disease. Bayer HealthCare and the Kidney Cancer Association (KCA) have therefore announced the European “Advances in Renal Cancer” Journalists’ Award 2011. For the third time, the prize honors journalistic work, in which journalists cover the issue of renal cancer in a critical, but yet objective manner. It is endowed with the sum of Euro 7,500 and awarded to reports which have been published in print media, radio, television, or film.

„Malignant tumors in kidney cells are one of the most insidious types of cancer worldwide. They are often only diagnosed at a late stage and have a significant unmet medical need”,says Helmut Schäfers, Head of Corporate Communications Europe, Bayer HealthCare, Leverkusen, Germany. “By announcing this award together with specialists in this field, we want to stimulate journalists to report on the disease and publish more information about renal carcinoma and current medical developments.” Carrie Konosky, Director of Development & Public Affairs, Kidney Cancer Association, USA, explains: “Our objective is to raise awareness of the symptoms and risk factors of renal cancer and inform the public about new, diagnostic therapy options. That is why the media are an important partner for us.”

Journalists may submit their applications by March 1, 2011, to the Kidney Cancer Association – Project Office, P.O. Box 90 06 48, 51116 Cologne, Germany. The statutes are also available for download online at Bayer HealthCare’s press portal at www.viva.vita.bayerhealthcare.com.

The relevant stories must have been published between March 1, 2010, and February 28, 2011. The jury will award the prize to what seems to be the year’s most outstanding medical journalistic publication or program in Europe. Members of the jury are up to four representatives from journalistic organizations, one urologist and one oncologist, one member of the Kidney Cancer Association as well as one non-voting representative from Bayer HealthCare. The award will be presented in Warsaw, Poland, in May 2011.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the health care and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Bayer Schering Pharma, Consumer Care and Medical Care divisions. Bayer HealthCare’s aim is to discover, manufacture and market products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

About Bayer Schering Pharma
Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at www.bayerscheringpharma.de.

Bayer HealthCare AG
Helmut Schäfers
Corporate Communications
51368 Leverkusen, Germany
E-Mail: helmut.schaefers@bayerhealthcare.com

This release was published on openPR.